Article info
Inflammatory bowel disease
Original research
Agonist that activates the µ-opioid receptor in acidified microenvironments inhibits colitis pain without side effects
- Correspondence to Professor Nigel W Bunnett, Department of Molecular Pathobiology, New York University College of Dentistry, New York, NY 10010, USA; nwb2{at}nyu.edu
Citation
Agonist that activates the µ-opioid receptor in acidified microenvironments inhibits colitis pain without side effects
Publication history
- Received January 8, 2021
- Revised February 15, 2021
- Accepted March 9, 2021
- First published March 30, 2021.
Online issue publication
March 07, 2022
Article Versions
- Previous version (30 March 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.